Next Article in Journal
Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results
Previous Article in Journal
Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
Article

Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia

1
Department of Microbiology and Parasitology, College of Medicine, Jazan University, Jazan 45142, Saudi Arabia
2
Jazan University Hospital, Jazan University, Jazan 45142, Saudi Arabia
3
Medical Research Center, Jazan University, Jazan 45142, Saudi Arabia
4
Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia
5
Department of Medicine, College of Medicine, Jazan University, Jazan 45142, Saudi Arabia
6
College of Medicine, Jazan University, Jazan 45142, Saudi Arabia
*
Author to whom correspondence should be addressed.
Academic Editor: Ralph A. Tripp
Vaccines 2021, 9(6), 674; https://doi.org/10.3390/vaccines9060674
Received: 18 May 2021 / Revised: 11 June 2021 / Accepted: 16 June 2021 / Published: 18 June 2021
Background: Pfizer-BioNTech and Oxford-AstraZeneca are recently introduced vaccines to combat COVID-19 pandemic. During clinical trials, mild to moderate side effects have been associated with these vaccines. Thus, we aimed to evaluate short-term post-vaccination side effects. Methods: Cross-sectional, retrospective study using an online questionnaire was conducted among COVID-19 vaccines recipients in Saudi Arabia. General and demographic data were collected, and vaccine-associated side effects after receiving at least one dose of each vaccine were evaluated. Results: Our final sample consisted of 515 participants with a median age of 26 years. Most of the study participants were female (57%). Nearly 13% of the study subjects have reported previous infections with SARS-CoV-2. Oxford-AstraZeneca and Pfizer-BioNTech vaccines have been received by 75% and 25% of the study participants, respectively. Side effects associated with COVID-19 vaccines have been reported by 60% of the study subjects, and most of them reported fatigue (90%), pain at the site of the injections (85%). Conclusion: Side effects that are reported post Oxford-AstraZeneca and Pfizer-BioNTech vaccines among our study participants are not different from those that were reported in the clinical trials, indicating safe profiles for both vaccines. Further studies are needed to evaluate the effectiveness of the current vaccines in protection against SARS-CoV-2 reinfections. View Full-Text
Keywords: COVID-19; SARS-CoV-2; vaccine; side effects COVID-19; SARS-CoV-2; vaccine; side effects
MDPI and ACS Style

Alhazmi, A.; Alamer, E.; Daws, D.; Hakami, M.; Darraj, M.; Abdelwahab, S.; Maghfuri, A.; Algaissi, A. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines 2021, 9, 674. https://doi.org/10.3390/vaccines9060674

AMA Style

Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, Maghfuri A, Algaissi A. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines. 2021; 9(6):674. https://doi.org/10.3390/vaccines9060674

Chicago/Turabian Style

Alhazmi, Abdulaziz, Edrous Alamer, Dalia Daws, Mashael Hakami, Majid Darraj, Siddig Abdelwahab, Amani Maghfuri, and Abdullah Algaissi. 2021. "Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia" Vaccines 9, no. 6: 674. https://doi.org/10.3390/vaccines9060674

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop